Role of cytochrome P‐450 in ochratoxin a‐stimulated lipid peroxidation
- 1 September 1991
- journal article
- research article
- Published by Wiley in Journal of Biochemical Toxicology
- Vol. 6 (3) , 203-209
- https://doi.org/10.1002/jbt.2570060306
Abstract
The role of cytochrome P-450 in the stimulation of lipid peroxidation by the nephrotoxic mycotoxin ochratoxin A has been investigated. Ochratoxin A was previously shown to markedly stimulate lipid peroxidation in a reconstituted system consisting of phospholipid vesicles, NADPH-cytochrome P-450 reductase, Fe3+, ethylenediaminetetra-acetic acid (EDTA), and reduced nicotinamide adenine dinucleotide phosphate (NADPH). We now show that purified cytochrome P-450IIB1 could effectively replace EDTA in stimulating lipid peroxidation suggesting that it could mediate the transfer of electrons from NADPH to Fe3+. Cobalt protoporphyrin is known to cause an extensive and long-lasting depletion of hepatic cytochrome P-450 in rats, and it has been used to evaluate the role of hepatic cytochrome P-450 in xenobiotic metabolism and toxicity. We have observed that microsomes isolated from livers of cobalt protoporphyrin-pretreated rats underwent ochratoxin A-dependent lipid peroxidation much more slowly than control microsomes. Also, the level of ethane exhaled (an index of in vivo lipid peroxidation) on ochratoxin A administration was much lower in cobalt protoporphyrin-pretreated rats than in control rats. Taken together, these results provide evidence for the stimulatory role of cytochrome P-450 in ochratoxin A-induced lipid peroxidation in a reconstituted system and strongly implicate its role in microsomal and in vivo ochratoxin A-induced lipid peroxidation.Keywords
This publication has 16 references indexed in Scilit:
- Mechanism of ochratoxin a stimulated lipid peroxidationBiochemical Pharmacology, 1990
- A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administrationBiochemical Pharmacology, 1989
- Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymesBiochemical Pharmacology, 1989
- Lipid peroxidation as a possible cause of ochratoxin a toxicityBiochemical Pharmacology, 1988
- Purification of NADPH:cytochrome c (cytochrome P-450) reductase from hamster liver microsomes by detergent extraction and affinity chromatographyAnalytical Biochemistry, 1987
- Inhibition of hepatic microsomal lipid peroxidation by drug substrates without drug metabolismBiochemical Pharmacology, 1980
- NADPH-dependent lipid peroxidation catalyzed by purified NADPH-cytochrome c reductase from rat liver microsomesBiochemical and Biophysical Research Communications, 1972
- Evidence for the involvement of iron in the ADP-activatedperoxidation of lipids in microsomes and mitochondriaBiochemical and Biophysical Research Communications, 1964
- Inhibition of the TPNH-linked lipid peroxidation of liver microsomes by drugs undergoing oxidative demethylationBiochemical and Biophysical Research Communications, 1963
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959